Astragaloside I is primarily used in pharmaceutical and nutraceutical research due to its potential bioactive properties. It is investigated for its role in supporting immune function, showing immunomodulatory effects that may enhance the body’s natural defense mechanisms. Studies suggest it contributes to anti-inflammatory responses, making it a candidate for managing chronic inflammatory conditions. It also exhibits antioxidant activity, helping to reduce oxidative stress in cells, which is beneficial in aging and degenerative diseases. In cardiovascular research, Astragaloside I has been explored for its ability to protect heart tissue, particularly in ischemia-reperfusion injury models, indicating potential in supporting heart health. Additionally, it is studied for hepatoprotective effects, offering protection against liver damage caused by toxins or disease. Due to these properties, it is often included in herbal extracts and formulations aimed at improving vitality and resilience, especially in traditional medicine-based therapies.